Cookies

By selecting “Accept all” you expressly consent to our use of cookies for statistics and marketing. Google and Meta will learn that you are interested in a blood test, combine this with data from other websites into advertising profiles and also process it in the USA. Withdraw anytime in the footer.

Body fat percentage and mood: a link that runs both ways

Dr. Andrej Busch

Dr. iur. · Founder & CEO, CHIRAYOU

8 min

Illustrative photo: Body fat percentage and mood: a link that runs both ways

According to a meta-analysis of genetic studies in Obesity Reviews (2026), more body fat is linked to a slightly higher risk of depression. A large genetic analysis in BMC Medicine (2024) also shows that depression, in turn, influences body weight. Body fat percentage therefore matters for both metabolism and mood, and it changes slowly enough that a trend reveals more than a single measurement.

Key points at a glance

  • A meta-analysis of 23 Mendelian randomization studies (Obesity Reviews, 2026) found that overall fat mass slightly raises the risk of depression, with an odds ratio of 1.09.
  • According to a genetic analysis using data from more than 1.3 million people (BMC Medicine, 2024), depression and body weight influence each other, with similar strength in both directions.
  • In a cohort of almost 500,000 adults from the UK Biobank (The Lancet Healthy Longevity, 2024), obesity was linked to a 1.40-fold higher risk of a first disease associated with hallmarks of cellular ageing.
  • Most of these studies measure fat mass using body mass index (BMI), which does not separate fat from muscle. Body fat percentage does.
  • Because body fat percentage shifts over weeks and months, only repeated measurement shows whether a change is working.

Does more body fat worsen mood?

Genetic studies suggest that more body fat probably raises the risk of depression slightly. The meta-analysis in Obesity Reviews (2026) screened 57 Mendelian randomization studies and statistically pooled 23 of them, with 44 estimates. The result: overall fat mass was causally linked to depression, with an odds ratio of 1.09, meaning roughly 9 percent higher odds.

Mendelian randomization uses a kind of natural lottery. Gene variants that lead to more or less fat mass are distributed at random at conception. Comparing people with different variants makes it easier to rule out lifestyle and life circumstances as confounders than in classic observational studies.

The researchers are clear about the limits: the effect is moderate, and the individual results vary widely. The meta-analysis found no difference between women and men. For schizophrenia and obsessive-compulsive disorder there are only indications, and for other mental illnesses the picture remains unclear. The authors conclude that weight management could also benefit mental health.

Why do depression and body weight influence each other?

According to genetic analyses, depression and body weight share part of their genetic basis and act on each other in both directions. The analysis in BMC Medicine (2024) used data from more than 1.3 million people on depression and 806,834 people on BMI. It found 16 shared gene loci that shift both traits in the same direction, and a causal link in both directions with effects of comparable size.

Where this overlap sits is revealing: mainly in 6 brain regions, especially the nucleus accumbens and the anterior cingulate cortex. The strongest shared gene, NEGR1, was less active in the brain tissue of people with depression and obesity than in healthy controls. The connection between fat mass and mood therefore reaches into the brain.

The form a depression takes also plays a role. A meta-analysis of observational studies including 14,757 people with depression in Obesity Reviews (2021) found that atypical depression was linked to a BMI 2.55 points higher than the melancholic form. The researchers point to symptoms such as changes in appetite and changes in weight.

What does body fat have to do with cellular ageing?

Obesity is linked to a markedly higher risk of diseases associated with hallmarks of cellular ageing. A multicohort study of 496,530 adults from the UK Biobank and 83,249 adults from Finnish cohorts in The Lancet Healthy Longevity (2024) followed 83 such diseases over an average of about 13 years. Adults with obesity had a 1.40-fold higher risk of the first of these diseases than people of healthy weight, even after accounting for lifestyle and depression.

The hallmarks studied include shortened telomeres (the protective caps on chromosomes), disrupted nutrient signalling and dysfunction of the mitochondria, the power plants of the cells. In both datasets, smoking, heavy drinking, physical inactivity and depression were less strongly linked to these diseases than obesity. Between 45 and 60 percent of the excess mortality associated with obesity could be attributed to these diseases. As an observational study, it shows an association, not proof of cause and effect.

Why does body fat percentage tell you more than the scale?

Body fat percentage shows how much of your weight is fat, something the scale and BMI cannot distinguish. The studies in this article mostly work with BMI; only the meta-analysis in Obesity Reviews (2026) also included measures of body composition. If you build muscle while losing fat, the scale may barely move, but your body fat percentage will.

Body fat percentage shifts slowly when energy balance, activity and protein intake change over the long term. A single measurement is therefore a snapshot. Only a baseline measurement and regular repeats show which direction you are heading in and whether a change is taking effect.

At CHIRAYOU, body fat percentage sits alongside the WHO-5, a short, validated questionnaire on mental well-being. This way you see body and mood in the same trend, week by week.

When to see a doctor?

If your mood has been low for weeks, or your appetite and weight change noticeably for no apparent reason, talk to your GP. A body fat percentage or a questionnaire score is not a diagnosis. A doctor decides what a value means for you and whether further investigation makes sense. In an acute mental health crisis, seek medical help immediately or call the emergency number 112.

How Chirayou can help

CHIRAYOU is a doctor-led online program for preventive health. In the 90-day program, a smart scale measures your body fat percentage, separately from visceral fat, which we score as a signal of metabolic inflammation. Added to this are the WHO-5, the PSS-4 for perceived stress, and heart rate variability (HRV) as a physiological stress signal. The at-home blood test adds, among other markers, apolipoprotein B (ApoB), the count of cholesterol-carrying particles that build up in artery walls, as well as triglycerides and hsCRP.

The process is called Test, Plan, Act. You measure, receive 3 to 5 interventions for the markers that need the most attention, such as a protein and strength training plan, and put them into practice in daily life. Doctors discuss the results with you. Weekly updates and the full re-test after 90 days show whether your body fat percentage has actually moved.

Your next step: start the CHIRAYOU 90-day program and see your body fat percentage and your well-being over time.

The bottom line

Body fat is about more than appearance. Genetic studies suggest that more fat mass slightly raises the risk of depression and that depression in turn affects weight, and large cohorts link obesity to diseases of cellular ageing. If you track your body fat percentage together with your well-being over time, you see early where both are heading.

Frequently asked questions

Can being overweight cause depression?

According to genetic studies, more fat mass slightly raises the risk of depression, but it does not inevitably lead to it. A meta-analysis of Mendelian randomization studies in Obesity Reviews (2026) found an odds ratio of 1.09, a moderate effect with wide variation between studies. A genetic analysis in BMC Medicine (2024) also shows that the link runs the other way too. Whether depression is present is for a doctor to determine.

Is body fat percentage more meaningful than BMI?

Body fat percentage distinguishes fat from muscle, while BMI only relates weight to height. A muscular person can therefore have a high BMI without carrying much fat. The large studies on fat mass, mood and cellular ageing mostly work with BMI. For your personal trend, body fat percentage gives the more accurate picture of what your weight is made of.

How often should I measure my body fat percentage?

Measure it regularly enough to see a trend, because body fat percentage changes over weeks and months. In the CHIRAYOU program, the smart scale updates the value weekly, and every 90 days there is a full assessment of all 20 markers. This lets you see whether a direction holds over several weeks, rather than reacting to a single measurement.

What is the difference between body fat percentage and visceral fat?

Body fat percentage describes all fat relative to lean mass, while visceral fat refers only to the deep abdominal fat around the organs. At CHIRAYOU, body fat percentage belongs to the Fitness category and stands for body composition and functional load. Visceral fat belongs to the Reset category and is scored as a signal of metabolic inflammation, because it releases pro-inflammatory messengers. Both values come from the scale and are assessed separately.

This article is for general information only and does not replace medical advice, diagnosis or treatment.

References

  1. Gao M, Doody PJ, Koutoukidis DA, et al. (2026). The Causal Role of Adiposity in Mental Illness: A Systematic Review and Meta-Analysis of Mendelian Randomization Studies. Obesity reviews : an official journal of the International Association for the Study of Obesity. pubmed.ncbi.nlm.nih.gov
  2. Zhang H, Zheng R, Yu B, et al. (2024). Dissecting shared genetic architecture between depression and body mass index. BMC medicine. pubmed.ncbi.nlm.nih.gov
  3. Kivimäki M, Frank P, Pentti J, et al. (2024). Obesity and risk of diseases associated with hallmarks of cellular ageing: a multicohort study. The lancet. Healthy longevity. pubmed.ncbi.nlm.nih.gov
  4. Silva DA, Coutinho EDSF, Ferriani LO, et al. (2021). Depression subtypes and obesity in adults: A systematic review and meta-analysis. Obesity reviews : an official journal of the International Association for the Study of Obesity. pubmed.ncbi.nlm.nih.gov

Related biomarkers

Cookie settings

You decide for each purpose separately. Without your consent everything below stays off, and the website still works. By selecting “Accept all” or “Save selection” you consent to information being stored on and read from your device (Section 25(1) TDDDG) and to us and the providers named processing your data for the purposes you choose (Art. 6(1)(a) GDPR). For marketing you also expressly consent to Google or Meta learning that you are interested in a blood test, and to Google also learning whether you have ordered one (Art. 9(2)(a) GDPR). After you consent, we load the chosen services via Google Tag Manager from servers of Google Ireland Ltd., which receives your IP address. We remember your choice for 6 months and ask again sooner if purposes or providers change. You can withdraw your consent at any time here or via “Cookie settings” in the footer. Withdrawal takes effect from then on; processing before it remains lawful. More in our privacy policy.

Necessary

Stores your choice in this banner: cookie “lr_consent” (6 months, set by us; only version, choice and time, no identifier). Otherwise only where a function needs it: your language choice, the unlocking of journal articles after you sign up for the newsletter and the state of your order in your browser’s local storage (no identifier); in the checkout, the cookies “__stripe_mid” (1 year) and “__stripe_sid” (30 minutes) of our payment provider Stripe Payments Europe, Ltd. (Ireland) to prevent fraud; to protect against attacks and bots, the cookies “__cf_bm” (30 minutes) and “cf_clearance” (30 minutes) of our host Cloudflare, Inc. (USA), which also checks browser characteristics for this. Our own count of page views stores and reads nothing on your device and does not recognise you.

We analyse which pages are visited and which buttons are used, and we test variants of our pages (A/B tests), to improve the website. For this we use Google Analytics 4: Google receives your IP address, device and browser details, the pages and events you view and a random identifier, and processes the data on our behalf. For A/B tests our server assigns you to a test group and remembers it in a cookie.

Providers: CHIRAYOU GmbH (A/B tests), Google Ireland Limited, Ireland (processor)

Third country: Also processed in the USA (EU-US Data Privacy Framework, Art. 45 GDPR)

Cookies: _ga (6 months), _ga_N543GR4LNC (6 months), ch_abid (6 months), ch_ab_… (6 months)

Google Ads measures whether you order a blood test after clicking one of our ads, and uses this to serve, optimise and personalise ads. For this Google stores identifiers on your device and receives the pages you view (with their address), your IP address, device details and events such as starting and completing an order (with order value). Google processes these data as an independent controller also for its own purposes, combines them with other data about you, for example from your Google account and from other websites, and builds advertising profiles from them. In doing so Google learns that you are interested in a blood test or have ordered one. You hereby expressly consent to this processing (Art. 9(2)(a) GDPR).

Providers: Google Ireland Limited, Ireland (independent controller)

Third country: Also processed in the USA (EU-US Data Privacy Framework, Art. 45 GDPR)

Cookies: _gcl_au (90 days), _gcl_aw (90 days), _gcl_gb (90 days), _gcl_gs (90 days), _gcl_ls (local storage, no expiry), Google cookies on google.com/doubleclick.net, e.g. IDE (up to 13 months)

Meta (Facebook, Instagram) uses the Meta Pixel to measure which of our pages and offers you view (including after clicking one of our ads), how intensively you use them and whether you sign up for our newsletter or send us a request through a form, and uses this to serve, optimise and personalise ads, including for people with similar characteristics. For this Meta stores identifiers on your device and receives the pages you view (with their address), your IP address, device details and these events, directly and also via the Meta Conversions API Gateway, which Meta runs on Amazon Web Services servers in the USA. Meta links the data to your Facebook or Instagram account and to data from other websites and builds advertising profiles from them. In doing so Meta learns that you are interested in a blood test. The Meta Pixel is not active in the checkout or on the page where you activate your account after an order, so we do not tell Meta whether you have placed an order. You hereby expressly consent to this processing (Art. 9(2)(a) GDPR). We and Meta are joint controllers for the collection and transmission; Meta alone is responsible for everything after that.

Providers: Meta Platforms Ireland Limited, Ireland (joint controller with us for collection and transmission)

Third country: Also processed in the USA (EU-US Data Privacy Framework, Art. 45 GDPR)

Cookies: _fbp (90 days), _fbc (90 days, only after clicking a Meta ad), Meta cookies on facebook.com, e.g. fr (90 days)